Found: 67
Select item for more details and to access through your institution.
Revision of antifungal strategies definitions for invasive fungal infections (proven/probable/possible) in 461 patients with haematological malignancies (REDEFI‐SEIFEM).
- Published in:
- Mycoses, 2024, v. 67, n. 8, p. 1, doi. 10.1111/myc.13781
- By:
- Publication type:
- Article
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission †
- Published in:
- Cancers, 2024, v. 16, n. 11, p. 2108, doi. 10.3390/cancers16112108
- By:
- Publication type:
- Article
Adapting the Fitness Criteria for Non-Intensive Treatments in Older Patients with Acute Myeloid Leukemia to the Use of Venetoclax-Hypomethylating Agents Combination—Practical Considerations from the Real-Life Experience of the Hematologists of the Rete Ematologica Lombarda
- Published in:
- Cancers, 2024, v. 16, n. 2, p. 386, doi. 10.3390/cancers16020386
- By:
- Publication type:
- Article
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 637, doi. 10.1111/bjh.19104
- By:
- Publication type:
- Article
Posaconazole and midostaurin in patients with FLT3‐mutated acute myeloid leukemia: Pharmacokinetic interactions and clinical facts in a real life study.
- Published in:
- CTS: Clinical & Translational Science, 2023, v. 16, n. 10, p. 1876, doi. 10.1111/cts.13595
- By:
- Publication type:
- Article
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.
- Published in:
- Cancers, 2023, v. 15, n. 18, p. 4623, doi. 10.3390/cancers15184623
- By:
- Publication type:
- Article
Multicenter Observational Retrospective Study on Febrile Events in Patients with Acute Myeloid Leukemia Treated with Cpx-351 in "Real-Life": The SEIFEM Experience.
- Published in:
- Cancers, 2023, v. 15, n. 13, p. 3457, doi. 10.3390/cancers15133457
- By:
- Publication type:
- Article
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia–like or acute lymphoblastic leukemia–like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study
- Published in:
- Annals of Hematology, 2023, v. 102, n. 5, p. 1099, doi. 10.1007/s00277-023-05162-0
- By:
- Publication type:
- Article
Prospective multicenter study on infectious complications and clinical outcome of 230 unfit acute myeloid leukemia patients receiving first‐line therapy with hypomethylating agents alone or in combination with Venetoclax.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. E80, doi. 10.1002/ajh.26846
- By:
- Publication type:
- Article
AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 7, p. 992, doi. 10.1002/cncr.34608
- By:
- Publication type:
- Article
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01423-7
- By:
- Publication type:
- Article
Real-life monocentric experience of venetoclax-based regimens for acute myeloid leukemia.
- Published in:
- Frontiers in Oncology, 2023, v. 13, p. 1, doi. 10.3389/fonc.2023.1149298
- By:
- Publication type:
- Article
Incidence, treatment and outcome of central nervous system relapse in adult acute lymphoblastic leukaemia patients treated front‐line with paediatric‐inspired regimens: A retrospective multicentre Campus ALL study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 4, p. 440, doi. 10.1111/bjh.18537
- By:
- Publication type:
- Article
SARS‐CoV‐2 infection in patients with chronic lymphocytic leukemia: The Italian Hematology Alliance on COVID‐19 cohort.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 1, p. 128, doi. 10.1002/hon.3092
- By:
- Publication type:
- Article
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
- Published in:
- Mycoses, 2023, v. 66, n. 1, p. 35, doi. 10.1111/myc.13524
- By:
- Publication type:
- Article
Secondary infections worsen the outcome of COVID‐19 in patients with hematological malignancies: A report from the ITA‐HEMA‐COV.
- Published in:
- Hematological Oncology, 2022, v. 40, n. 5, p. 846, doi. 10.1002/hon.3048
- By:
- Publication type:
- Article
Impact of severe acute respiratory syndrome coronavirus‐2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group.
- Published in:
- British Journal of Haematology, 2022, v. 199, n. 4, p. 507, doi. 10.1111/bjh.18396
- By:
- Publication type:
- Article
Use of CYP3Ai and impact on outcomes in patients with acute myeloid leukemia treated with venetoclax plus azacitidine in the VIALE‐A study.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. E422, doi. 10.1002/ajh.26707
- By:
- Publication type:
- Article
Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2994, doi. 10.3390/cancers14122994
- By:
- Publication type:
- Article
Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 3012, doi. 10.3390/cancers14123012
- By:
- Publication type:
- Article
High Incidence of Invasive Fungal Diseases in Patients with FLT3-Mutated AML Treated with Midostaurin: Results of a Multicenter Observational SEIFEM Study.
- Published in:
- Journal of Fungi, 2022, v. 8, n. 6, p. 583, doi. 10.3390/jof8060583
- By:
- Publication type:
- Article
Venetoclax combinations delay the time to deterioration of HRQoL in unfit patients with acute myeloid leukemia.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 4, p. 1, doi. 10.1038/s41408-022-00668-8
- By:
- Publication type:
- Article
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1776, doi. 10.3390/jcm11071776
- By:
- Publication type:
- Article
Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016‐B survey.
- Published in:
- Mycoses, 2022, v. 65, n. 2, p. 171, doi. 10.1111/myc.13384
- By:
- Publication type:
- Article
Real-World Multicenter Experience in Tumor Debulking Prior to Blinatumomab Administration in Adult Patients With Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.804714
- By:
- Publication type:
- Article
COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 371, doi. 10.1111/bjh.17704
- By:
- Publication type:
- Article
Poster: AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S210, doi. 10.1016/S2152-2650(21)01316-1
- By:
- Publication type:
- Article
Poster: AML-272: Real-World Experience with Venetoclax-Based Regimens for the Treatment of Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S215, doi. 10.1016/S2152-2650(21)01353-7
- By:
- Publication type:
- Article
AML-272: Real-World Experience with Venetoclax-Based Regimens for the Treatment of Acute Myeloid Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S298, doi. 10.1016/S2152-2650(21)01710-9
- By:
- Publication type:
- Article
AML-347: A Preliminary Analysis of FLAM (Italian Non-Interventional Multi-Center Study of FLT3-Mutated AML Patients): FLT3 Receptor Gene Mutational Analysis and FLT3 Inhibitor Administration in Real-Life Clinical Practice.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S307, doi. 10.1016/S2152-2650(21)01729-8
- By:
- Publication type:
- Article
Realizing Innate Potential: CAR-NK Cell Therapies for Acute Myeloid Leukemia.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1568, doi. 10.3390/cancers13071568
- By:
- Publication type:
- Article
Do high MICs predict the outcome in invasive fusariosis?
- Published in:
- 2021
- By:
- Publication type:
- journal article
Nelarabine as salvage therapy and bridge to allogeneic stem cell transplant in 118 adult patients with relapsed/refractory T‐cell acute lymphoblastic leukemia/lymphoma. A CAMPUS ALL study.
- Published in:
- American Journal of Hematology, 2020, v. 95, n. 12, p. 1466, doi. 10.1002/ajh.25957
- By:
- Publication type:
- Article
Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00383-2
- By:
- Publication type:
- Article
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis.
- Published in:
- Mycoses, 2020, v. 63, n. 9, p. 900, doi. 10.1111/myc.13130
- By:
- Publication type:
- Article
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects.
- Published in:
- Frontiers in Oncology, 2020, p. 1, doi. 10.3389/fonc.2020.00273
- By:
- Publication type:
- Article
A bronchoalveolar lavage‐driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 10, p. 1104, doi. 10.1002/ajh.25585
- By:
- Publication type:
- Article
Real-world experience with decitabine as a first-line treatment in 306 elderly acute myeloid leukaemia patients unfit for intensive chemotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Epidemiology and treatment approaches in management of invasive fungal infections in hematological malignancies: Results from a single-centre study.
- Published in:
- PLoS ONE, 2019, v. 14, n. 5, p. 1, doi. 10.1371/journal.pone.0216715
- By:
- Publication type:
- Article
Fungaemia in haematological malignancies: SEIFEM‐2015 survey.
- Published in:
- European Journal of Clinical Investigation, 2019, v. 49, n. 5, p. N.PAG, doi. 10.1111/eci.13083
- By:
- Publication type:
- Article
A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.
- Published in:
- 2019
- By:
- Publication type:
- case study
Rhodotorula infection in haematological patient: Risk factors and outcome.
- Published in:
- Mycoses, 2019, v. 62, n. 3, p. 223, doi. 10.1111/myc.12875
- By:
- Publication type:
- Article
An Unusual Coexistence of Primary Central Nervous System Non-Hodgkin's Lymphoma and Acute Promyelocytic Leukemia.
- Published in:
- Case Reports in Hematology, 2018, p. 1, doi. 10.1155/2018/2741939
- By:
- Publication type:
- Article
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Secondary acute myeloid leukaemia in elderly patients: Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions. An analysis of 280 patients by the network rete ematologica lombarda (REL).
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. E54, doi. 10.1002/ajh.24977
- By:
- Publication type:
- Article
FarmaREL: An Italian pharmacovigilance project to monitor and evaluate adverse drug reactions in haematologic patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Clinical management of peripherally inserted central catheters compared to conventional central venous catheters in patients with hematological malignancies: A large multicenter study of the REL GROUP (Rete Ematologica Lombarda - Lombardy Hematologic Network, Italy)
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 12, p. E656, doi. 10.1002/ajh.24903
- By:
- Publication type:
- Article
Mesenchymal Stem Cells in Myeloid Malignancies: A Focus on Immune Escaping and Therapeutic Implications.
- Published in:
- Stem Cells International, 2017, p. 1, doi. 10.1155/2017/6720594
- By:
- Publication type:
- Article
Acute myeloid leukemia and pregnancy: clinical experience from a single center and a review of the literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia.
- Published in:
- Histopathology, 2017, v. 70, n. 6, p. 1000, doi. 10.1111/his.13166
- By:
- Publication type:
- Article